SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-22-046454
Filing Date
2022-12-21
Accepted
2022-12-21 07:45:20
Documents
5
Period of Report
2022-12-21

Document Format Files

Seq Description Document Type Size
1 6-K brhc10045712_6k.htm 6-K 14600
2 EXHIBIT 10.1 brhc10045712_ex10-1.htm EX-10.1 58737
3 EXHIBIT 10.2 brhc10045712_ex10-2.htm EX-10.2 64613
4 EXHIBIT 99.1 brhc10045712_ex99-1.htm EX-99.1 17929
5 image1.jpg GRAPHIC 36872
  Complete submission text file 0001140361-22-046454.txt   207777
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 221476499
SIC: 2834 Pharmaceutical Preparations